Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10553405 | 0.89 | RECQL (0.43) | RECQLHTR6ALDH1A1LMNAMAPT | |
| SCHEMBL369194 | 0.83 | CA12 (0.52) | RECQLHTR6ALDH1A1LMNAMAPT | |
| SCHEMBL30276218 | 0.83 | CA12 (0.52) | RECQLHTR6ALDH1A1LMNAMAPT | |
| SCHEMBL21115189 | 0.81 | HTR6 (0.44) | RECQLHTR6ALDH1A1LMNAMAPT | |
| SCHEMBL4271243 | 0.78 | RECQL (0.57) | RECQLHTR6ALDH1A1LMNAMAPT | |
| SCHEMBL5833077 | 0.77 | PPARG (0.44) | RECQLHTR6ALDH1A1LMNAMAPT | |
| SCHEMBL4276540 | 0.77 | RECQL (0.56) | RECQLHTR6ALDH1A1LMNAMAPT | |
| SCHEMBL20853109 | 0.77 | PTGDR2 (0.42) | RECQLHTR6ALDH1A1LMNAMAPT | |
| SCHEMBL17433427 | 0.77 | LMNA (0.40) | RECQLHTR6ALDH1A1LMNAMAPT | |
| SCHEMBL4035724 | 0.76 | ALDH1A1 (0.52) | RECQLHTR6ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10039755-B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2018-08-07 | — | — | US | disclosed |
| US-10039755-B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2018-08-07 | — | — | US | disclosed |
| US-20180161316-A1 | 2-(AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2018-06-14 | — | — | US | disclosed |
| US-20180161316-A1 | 2-(AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2018-06-14 | — | — | US | disclosed |
| US-9833449-B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2017-12-05 | — | — | US | disclosed |
| US-9833449-B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2017-12-05 | — | — | US | disclosed |
| US-20170119750-A1 | 2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2017-05-04 | — | — | US | disclosed |
| US-20170119750-A1 | 2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2017-05-04 | — | — | US | disclosed |
| US-20170119750-A1 | 2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2017-05-04 | — | — | US | disclosed |
| US-9518054-B2 | 2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2016-12-13 | — | — | US | disclosed |
| US-9127003-B2 | 2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2015-09-08 | — | — | US | disclosed |
| US-9127003-B2 | 2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2015-09-08 | — | — | US | disclosed |
| US-20150175600-A1 | 2-(AZAINDOL-2-YL)BENZIMIDAZOLES AS PAD4 INHIBITORS | Glaxo Group Limited a corporation | 2015-06-25 | — | — | US | disclosed |
| US-20150175600-A1 | 2-(AZAINDOL-2-YL)BENZIMIDAZOLES AS PAD4 INHIBITORS | Glaxo Group Limited a corporation | 2015-06-25 | — | — | US | disclosed |
| US-20150175600-A1 | 2-(AZAINDOL-2-YL)BENZIMIDAZOLES AS PAD4 INHIBITORS | Glaxo Group Limited a corporation | 2015-06-25 | — | — | US | disclosed |
| EP-2877467-A1 | 2 - (AZAINDOL- 2 -YL) BENZ IMIDAZOLES AS PAD4 INHIBITORS | Glaxo Group Limited (GB) | 2015-06-03 | — | — | EP | disclosed |
| CN-104470919-A | 2 - (azaindol- 2 -yl) benz imidazoles as pad4 inhibitors | GLAXO GROUP LTD | 2015-03-25 | — | — | CN | disclosed |
| WO-2014015905-A1 | 2 - (AZAINDOL- 2 -YL) BENZ IMIDAZOLES AS PAD4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2014-01-30 | — | — | WO | disclosed |
| EP-1732566-A2 | 6-AZAINDOLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2006-12-20 | — | — | EP | disclosed |
| WO-2005097129-A2 | 6-AZAINDOLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10039755-B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | PADI1, PADI4, PADI2 | RECQL 476/4885HTR6 2651/4885ALDH1A1 98/4885 |
| US-20150175600-A1 | 2-(AZAINDOL-2-YL)BENZIMIDAZOLES AS PAD4 INHIBITORS | PADI1, PADI4, PADI2 | RECQL 390/4885HTR6 2505/4885ALDH1A1 77/4885 |
| US-20180161316-A1 | 2-(AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | PADI1, PADI4, PADI2 | RECQL 490/4885HTR6 2600/4885ALDH1A1 107/4885 |
| US-20170119750-A1 | 2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | PADI1, PADI4, PADI2 | RECQL 390/4885HTR6 2517/4885ALDH1A1 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.